Extended maturity for credit facility

The maturity of the credit facility of SEK 100 million that Bactiguard received
as a loan commitment in November 2015, has been extended until 31 December, 2017
In November 2015 Bactiguard entered a credit facility agreement of SEK 130
million, consisting of a loan commitment of SEK 100 million and a renewal of
bank overdraft facility of SEK 30 million. Combined with the company’s cash
position, the credit facility secures the refinancing of Bactiguard’s bond loan,
which matures in December 2016. When utilizing the loan commitment, the credit
according to the original loan agreement, matured 30 June 2017.

The loan agreement has today been updated with an extension of the maturity of
the credit until 31 December, 2017. Other terms remain unchanged.

This is information that Bactiguard Holding AB (publ) is required to publish in
compliance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act. The information was submitted for publication on 9
August, 2016, at 18.30.

For further information, please contact:

Fredrik Järrsten, CFO, mobile: +46 725 500 089
About Bactiguard

Bactiguard is a Swedish medtech company with a global presence, offering a
solution that prevents healthcare associated infections caused by medical
devices. By preventing infections, we contribute to a reduced use of antibiotics
and the spread of multi-resistant bacteria, which is a growing problem
worldwide. We save lives, increase patient safety and significantly reduce the
cost for the healthcare and society. Our technology is well-proven, safe and
tissue friendly and consist of a thin layer of noble metals that prevents
bacterial growth. The coating can be applied on almost all medical devices.
Bactiguard-coated urinary catheters are market leading in the US and Japan and
the company has also its own product portfolio consisting of Foley catheters,
central venous catheters and endotracheal tubes. Bactiguard is a growth company,
focused on markets in Europe, Middle East, Asia and Latin America. The company
has about 60 employees worldwide, mainly at the headquarters in Stockholm and
the production facility in Malaysia and is listed on Nasdaq Stockholm. Read more
about Bactiguard at www.bactiguard.com